Memorializing Governor Kathy Hochul to proclaim May 14, 2026, as IgA Nephropathy Awareness Day in the State of New York
Assembly Resolution No. 1359 is a memorializing resolution that asks Governor Kathy Hochul to proclaim May 14, 2026, as IgA Nephropathy Awareness Day in New York State. The resolution describes IgA nephropathy (IgAN) as an autoimmune kidney disease that can damage the glomerulus, impair blood filtration, and in severe cases lead to end-stage kidney disease requiring dialysis or kidney transplantation. It also notes the role of the IgA Nephropathy Foundation, founded by Bonnie Schneider, in supporting affected individuals and families.
The resolution is primarily commemorative and educational. It aims to raise public awareness of IgAN, encourage early diagnosis and treatment, and recognize the people and families affected by the disease. The text frames the observance as part of the Legislature’s tradition of designating official awareness days for serious illnesses and health conditions.
Because this is a resolution memorializing the Governor rather than a bill creating or amending statutory law, it does not directly change New York’s laws, regulations, or agency duties. Its practical effect is symbolic: if proclaimed, it would establish an awareness day and may help promote outreach, education, and advocacy around kidney disease, autoimmune disorders, and patient support efforts. The resolution also directs that copies be sent to the Governor and the IgA Nephropathy Foundation.
The tone of the resolution is strongly supportive and sympathetic toward people living with IgA nephropathy and their families. The Legislature presents the measure as consistent with its tradition of recognizing health awareness days and emphasizes the importance of greater public awareness, early diagnosis, and treatment. No opposition or dissent is reflected in the provided materials, and there is no recorded committee debate or vote history in the context supplied.
There is no evident policy contention in the text or accompanying context. The measure does not appear to involve funding, regulatory mandates, or changes to rights or benefits, which typically generate controversy. Any discussion implied by the resolution is centered on public awareness and recognition of a serious kidney disease, with support coming from the IgA Nephropathy Foundation and the Legislature’s general commemorative practice.